Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
Titel:
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
Auteur:
Giugliano, Robert P Pedersen, Terje R Park, Jeong-Gun De Ferrari, Gaetano M Gaciong, Zbigniew A Ceska, Richard Toth, Kalman Gouni-Berthold, Ioanna Lopez-Miranda, Jose Schiele, François Mach, François Ott, Brian R Kanevsky, Estella Pineda, Armando Lira Somaratne, Ransi Wasserman, Scott M Keech, Anthony C Sever, Peter S Sabatine, Marc S